Skip to content

Clairfield advises Weldon Biotech on sale of its POCT division to Everlife

Weldon Biotech India Private Limited, an Indian manufacturer and distributor of in vitro diagnostic products (IVD), sold its i-chroma brand business (Boditech Med Inc., Korea) to CPC Diagnostics Pvt. Ltd., a leading provider of clinical diagnostic products and services and the Indian subsidiary of Singaporean group Everlife.

Weldon Biotech India Private Limited, an Indian manufacturer and distributor of in vitro diagnostic products (IVD), sold its i-chroma brand business (Boditech Med Inc., Korea) to CPC Diagnostics Pvt. Ltd., a leading provider of clinical diagnostic products and services and the Indian subsidiary of the Singaporean group Everlife.

Weldon Biotech India Private Limited is a manufacturer and distributor of IVD products. It is the distributor in India of point-of-care testing (POCT) products manufactured by Boditech Med Inc. located in Korea. An i-chroma measures the presence of various biomarkers for cardiac disorders, cancer, hormonal disorders, infectious diseases, autoimmune diseases, and metabolic diseases.

CPC Diagnostics Pvt. Ltd. is a leading provider of clinical diagnostic products and services in India, Sri Lanka, Nepal and Bangladesh, and the Indian subsidiary of Everlife, a platform of the Everstone Group. It is one of the leading providers of diagnostic products and solutions to clinical and scientific laboratories in south and southeast Asia.

This transaction follows on an earlier collaboration agreement signed between Everlife and Boditech in November 2021 to introduce Boditech’s EZ-POC brand to India. The acquisition paves the way for CPC Diagnostics to enter the growing POCT business in India.

Clairfield International acted as exclusive financial advisor to Weldon Biotech India Private Limited. This is Clairfield’s second transaction with Everlife, having previously identified Everlife as the perfect home for CPC Diagnostics, the platform of Everlife’s current buy-and-build strategy in India, and our fifth transaction in the in vitro diagnostic products space in India.

Healthcare

Drapeau India Drapeau Singapore

sold its i-chroma business to

Advisor to the sell side

Services :

Mergers & acquisitions

Sectors :

Healthcare

Countries involved :

India
Singapore

Similar transactions

AWS Mittelstandsfonds, a Vienna-based growth equity fund focused on Austrian SMEs, sold its remaining shares in three portfolio companies to Evoco AG, a Zurich-based lower midmarket manager that invests in growth and buyout investments in Western Europe with a focus on the DACH region.

Read more

Healthcare

Drapeau Austria Drapeau Germany Drapeau Switzerland

Sale

Advisor to the sell side

NTOC, a Dutch specialist in in the manufacturing of medical decontamination and sterilization cassettes, was sold to Inomed Technology, a portfolio company of Initiative & Finance.

Healthcare

Drapeau Netherlands Drapeau Switzerland

Sale

Advisor to the sell side

Ottobock sold select assets in Freedom Innovations Inc. to Proteor, a France-based international group specialized in prosthetic and orthotic solutions.

Healthcare

Drapeau France Drapeau Germany Drapeau US

Sale

Advisor to the sell side

Laboratoires Humeau, a leading distributor of lab equipment in France and Africa, was sold to the French investor Intuitis.

Healthcare

Drapeau France

Sale

Advisor to the sell side

Hepro Group, a healthcare technology company, was sold to AddLife. The Hepro Group develops, designs and markets assistive technology for home care and welfare.

Read more

Healthcare

Drapeau Norway Drapeau Sweden

Sale

Advisor to the sell side

Flèche vers la gauche
Flèche vers la droite